tirzepatide vs semaglutide moa Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity BodyByBariatrics

You R, He X, Zeng Z, Zhan Y, Xiao Y, Xiao R

doi: 10.1172/jci.insight.133429 Summary Keywords GLP-1 receptor agonists, type 2 diabetes, eating behavior, weight loss, personalized medicine Citation Koide Y, Kato T, Hayashi M, Daido H, Maruyama T, Ishihara T, Nishimura K, Tsunekawa S and Yabe D (2025) Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study

By the way, Kara, the California Health Growers Council even certifies

Naltrexone isn't as widely known as Ozempic, but possibly one day

Nutrients, 13(12), 4359.